TrialJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2021

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.

Jacques P Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.